Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType DefinitionDescription dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
44859-7 Bacteria^^^7 Prid XXX Pt Nom Anaerobic culture   ACTIVE Bacteria # 7 identified in Specimen by Anaerobe culture   NAM DefinitionDescription                   MICRO   44859-7   Anaerobic culture     Observation       0 Bacteria Spec Anaerobe Cult org #7       N   Anaero; Anaerobe; Anaerobe Cult; Bact; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; To be specified in another part of the message; Unspecified 2.78 2.17                     Release 2.78: COMPONENT: Removed "Identified" from the component because it is implied by the Property "Prid"; 0
4486-7 Complement C3 fragment PrThr RBC Pt Ord     ACTIVE Complement C3 fragment [Presence] in Red Blood Cells   MIN DefinitionDescription                   HEM/BC   4486-7         Both       0 C3 Frg RBC Ql           Beta 1 C-globulin; C3 Frg; Comp; Complmt; Erythrocytes; Frag; Fragments; HEMATOLOGY/CELL COUNTS; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen 2.56 1                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
44860-5 Methoxyacetate/Creatinine MRto Urine Pt Qn     ACTIVE Methoxyacetate/Creatinine [Mass Ratio] in Urine   MIN DefinitionDescription                   DRUG/TOX   44860-5         Both       0 Methoxyacetate/Creat Ur       N   2-Methoxyacetic acid; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; MAA; Mass concentration ratio; Mass ratio; MCRto; Methoxyacetic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn 2.42 2.17                       0
44861-3 4-Hydroxymandelate/Creatinine MRto Urine Pt Qn     DISCOURAGED 4-Hydroxymandelate/Creatinine [Mass Ratio] in Urine   MIN DefinitionDescription                   CHEM   44861-3         Both       0 4OHMandelate/Creat Ur       N   2-Hydroxy-2-(4-hydroxyphenyl)acetate; 4-Hydroxy mandelate; 4-hydroxymanelic acid; 4OHMandelate; Chemistry; CR; Crea; Creat; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn 2.42 2.17       AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
44862-1 5-Alpha tetrahydro-11-Dehydrocorticosterone/Creatinine MRto Urine Pt Qn     ACTIVE 5-Alpha tetrahydro-11-Dehydrocorticosterone/Creatinine [Mass Ratio] in Urine   MIN DefinitionDescription     mg/g creatinine             CHEM   44862-1         Both       0 5-A THB/Creat Ur       N   5-A THB; Alfa; Chemistry; CR; Crea; Creat; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; THA; UA; UCr; UR; Urn 2.44 2.17               mg/g{creat}       0
44863-9 6-Alpha hydroxytetrahydro-11-Dehydrocorticosterone/Creatinine MRto Urine Pt Qn     ACTIVE 6-alpha-hydroxytetrahydro-11-Dehydrocorticosterone/Creatinine [Mass Ratio] in Urine   MIN DefinitionDescription     mg/g creatinine             CHEM   44863-9         Both       0 6A-OH-THA/Creat Ur       N   6A-OH-THA; Alfa; Chemistry; CR; Crea; Creat; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn 2.44 2.17               mg/g{creat}       0
44864-7 6-Alpha hydroxytetrahydro-11-Deoxycortisol/Creatinine MRto Urine Pt Qn     ACTIVE 6-Alpha hydroxytetrahydro-11-Deoxycortisol/Creatinine [Mass Ratio] in Urine   MIN DefinitionDescription     mg/g creatinine             CHEM   44864-7         Both       0 6A-OH-THS/Creat Ur       N   11DC; 6A-OH-THS; Alfa; Chemistry; Compound S; Cortexolone; Cortodoxone; CR; Crea; Creat; Deoxycortisol; Desoxycortisol; Mass concentration ratio; Mass ratio; MCRto; Metopirone; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn 2.44 2.17               mg/g{creat}       0
44865-4 Ammonium urate PrThr Calculus Pt Ord     ACTIVE Ammonium urate [Presence] in Stone   MIN DefinitionDescription                   CHEM   44865-4         Observation       0 Amm Urate Stone Ql       N   Amm; Amm Urate; Ammon; Ammonium acid urate; Ammonium biurate; Calc; Calculi; Chemistry; NH4; NH4U; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Stn; Stone; Stones; UA; Urates; Uric acid 2.56 2.17                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
44867-0 Iron.microscopic observation PrThr Body fld Pt Ord XXX stain   ACTIVE Iron.microscopic observation [Presence] in Body fluid by Other stain   MIN DefinitionDescription                   PATH   44867-0   XXX stain     Both       0 Iron Fld Ql Other Stn       N   B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Fe; Fl; Fld; FLU; Fluid; Ordinal; Other Stn; PATHOLOGY; Point in time; PR; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn 2.56 2.17                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
44868-8 Herpes simplex virus 1+2 DNA PrThr Vag Pt Ord Probe.amp.tar   ACTIVE Herpes simplex virus 1+2 DNA [Presence] in Vaginal fluid by NAA with probe detection   MIN DefinitionDescription                   MICRO   44868-8   Probe.amp.tar     Both       0 HSV1+2 DNA Vag Ql NAA+probe       N   3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital vaginal; Gyn; Gynecology; Herp splx; Herpes simplex virus type 1; Herpes simplex virus type 1+2; Herpes simplex virus type I+II; HSV; HSV 1+2; HSV1; HSV1+2; i; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Vag fld; Vag fluid; Vagina; Vaginal fluid 2.73 2.17                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
44869-6 Histoplasma capsulatum Ab PrThr Ser Pt Ord CIE   ACTIVE Histoplasma capsulatum Ab [Presence] in Serum by Counterimmunoelectrophoresis (CIE)   MIN DefinitionDescription                   MICRO   44869-6   CIE     Both       0 H capsul Ab Ser Ql CIE       N   ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Counterimmunoelectrophoresis; H capsul; H capsulatum; H farciminosum; Histo; Histopl; Histoplasma farciminosum; Histoplasmos; Histoplasmosis; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR 2.56 2.17                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
4487-5 Complement C3 fragment MCnc RBC Pt Qn     ACTIVE Complement C3 fragment [Mass/volume] in Red Blood Cells   MIN DefinitionDescription                   HEM/BC   4487-5         Both       0 C3 Frg RBC-mCnc       Y   Beta 1 C-globulin; C3 Frg; Comp; Complmt; Erythrocytes; Frag; Fragments; HEMATOLOGY/CELL COUNTS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles 2.73 1                       0
44870-4 Histoplasma capsulatum Ag PrThr Urine Pt Ord RIA   ACTIVE Histoplasma capsulatum Ag [Presence] in Urine by Radioimmunoassay (RIA)   MIN DefinitionDescription                   MICRO   44870-4   RIA     Both       0 H capsul Ag Ur Ql RIA       N   Antigen; Antigens; H capsul; H capsulatum; H farciminosum; Histo; Histopl; Histoplasma farciminosum; Histoplasmos; Histoplasmosis; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Radioimmunoassay; Random; Screen; UA; UR; Urn 2.56 2.17                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
44871-2 HIV 1 proviral DNA PrThr Bld Pt Ord Probe.amp.tar   ACTIVE HIV 1 proviral DNA [Presence] in Blood by NAA with probe detection   MIN DefinitionDescription                   MICRO   44871-2   Probe.amp.tar     Both       0 HIV 1 pro DNA Bld Ql NAA+probe       N   3 Self-Sustaining Sequence Replication; 3SR SR; AIDS; Amplif; Amplification; Amplified; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HIV type 1; HIV type I; HIV1; HIV1 proviral DNA; Human immunodeficiency virus; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood 2.73 2.17                     The Property has been changed from ACnc to Threshold to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
44872-0 HIV 1 p24 Ag PrThr Ser/Plas^Donor Pt Ord IA   ACTIVE HIV 1 p24 Ag [Presence] in Serum or Plasma from Donor by Immunoassay   MAJ DefinitionDescription                   MICRO   44872-0   IA     Both       0 HIV1 p24 Ag SerPl Donr Ql IA       N   AIDS; Antigen; Antigens; Donr; EIA; ELFA; ELISA; Enzyme immunoassay; HIV type 1; HIV type I; HIV1; HIV1 p24; Human immunodeficiency virus; i; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS 2.56 2.17                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. 0
44873-8 HIV 1+2 Ab PrThr Ser Pt Ord IB   ACTIVE HIV 1+2 Ab [Presence] in Serum by Immunoblot   MIN DefinitionDescription                   MICRO   44873-8   IB     Observation       0 HIV1+2 Ab Ser Ql IB       N   ABS; Aby; AIDS; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; HIV 1 & 2; HIV 1 and 2 Ab; HIV type 1; HIV type I; HIV1; HIV1+2; Human immunodeficiency virus; i; ID; II; Immune blot; Immunobl; Immunoblot; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serum; SR; WB; WBLOT; West blot; West blt; Western blot 2.73 2.17                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
44874-6 HTLV I+II RNA PrThr Ser Pt Ord Probe.amp.tar   ACTIVE HTLV I+II RNA [Presence] in Serum by NAA with probe detection   MIN DefinitionDescription                   MICRO   44874-6   Probe.amp.tar     Both       0 HTLV I+II RNA Ser Ql NAA+probe       N   2; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HTLV type 1+2; HTLV type I+II; Human T-cell Leukemia Virus; Human T-cell Lymphotrophic Virus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Serum; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification 2.63 2.17                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
44875-3 IgM Ag PrThr Skin Pt Ord IF   ACTIVE IgM Ag [Presence] in Skin by Immunofluorescence   MIN DefinitionDescription                   CHEM   44875-3   IF     Both       0 IgM Ag Skin Ql IF       N   ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; Chemistry; Dermatologic; DFA; Epidermis; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Integument; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Skn; Time Resolved Fluorescence; TRF 2.73 2.17                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
44876-1 Influenza virus A Ab PrThr CSF Pt Ord     ACTIVE Influenza virus A Ab [Presence] in Cerebral spinal fluid   MIN DefinitionDescription                   MICRO   44876-1         Both       0 FLUAV Ab CSF Ql       N   ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Avian influenza; Bird flu; Cerebral spinal fluid; Cerebrospinal Fl; FLUA; FLUAV; FLUV; Fowl plague; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid 2.56 2.17                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
44877-9 Insulin dependent diabetes mellitus PrThr ^Patient Pt Ord     ACTIVE Insulin dependent diabetes mellitus [Presence]   MIN DefinitionDescription                   MISC   44877-9         Observation       0 IDDM Patient Ql       N   DM; HUM; Humulin; IDDM; IH7; Insul; Lente; MISC; NPH; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Semilente; Sliding; Ultralente 2.73 2.17                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
44878-7 Staphylococcus aureus enterotoxin A sea gene PrThr XXX Pt Ord Probe.amp.tar   ACTIVE Staphylococcus aureus enterotoxin A sea gene [Presence] in Specimen by NAA with probe detection   MIN DefinitionDescription       See comments for sample results           MICRO   44878-7   Probe.amp.tar     Both       0 S aureus Etx A gene Spec Ql NAA+probe       N   3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Etx; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; m80; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; o71; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S aureus; S aureus Etx; S aureus Etx A; S aureus Etx A gene; Screen; SDA; sea; Spec; St a SEA; Staph; Staphylococcal enterotoxin; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified 2.69 2.17                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; Removed parentheses around "sea" gene in Component based on the current LOINC model. 0
44879-5 Staphylococcus aureus enterotoxin E see gene PrThr XXX Pt Ord Probe.amp.tar   ACTIVE Staphylococcus aureus enterotoxin E see gene [Presence] in Specimen by NAA with probe detection   MIN DefinitionDescription                   MICRO   44879-5   Probe.amp.tar     Both       0 S aureus Etx E gene Spec Ql NAA+probe       N   3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Etx; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; o71; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Rm225; S aureus; S aureus Etx; S aureus Etx E; S aureus Etx E gene; Screen; SDA; see; Spec; Staph; Staphylococcal enterotoxin; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified 2.69 2.17                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; Removed parentheses around "see" gene in Component based on the current LOINC model. 0
4488-3 Complement C3a MCnc Ser/Plas Pt Qn     ACTIVE Complement C3a [Mass/volume] in Serum or Plasma   MIN DefinitionDescription     mg/dL             HEM/BC   4488-3         Both       0 C3a SerPl-mCnc       Y   Comp; Complmt; HEMATOLOGY/CELL COUNTS; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.73 1               mg/dL       0
44880-3 Staphylococcus aureus enterotoxin B seb gene PrThr XXX Pt Ord Probe.amp.tar   ACTIVE Staphylococcus aureus enterotoxin B seb gene [Presence] in Specimen by NAA with probe detection   MIN DefinitionDescription                   MICRO   44880-3   Probe.amp.tar     Both       0 S aureus Etx B gene Spec Ql NAA+probe       N   3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Etx; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; m81; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; o71; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S aureus; S aureus Etx; S aureus Etx B; S aureus Etx B gene; Screen; SDA; seb; Spec; St a SEB; Staph; Staphylococcal enterotoxin; Strand Displacement Amplification; TMA; To be specified in another part of the message; Toxic shock syndrome enterotoxin b; Transcription mediated amplification; Unspecified 2.73 2.17                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; Removed parentheses around "seb" gene in Component based on the current LOINC model. 0
44881-1 Staphylococcus aureus toxic shock syndrome toxin gene PrThr XXX Pt Ord Probe.amp.tar   ACTIVE Staphylococcus aureus toxic shock syndrome toxin gene [Presence] in Specimen by NAA with probe detection   MIN DefinitionDescription                   MICRO   44881-1   Probe.amp.tar     Both       0 S aureus TSST gene Spec Ql NAA+probe       N   3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; o71; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S aureus; S aureus TSST gene; Screen; SDA; Spec; Staph; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified 2.69 2.17                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
104,672 results found